Claudia Pastori

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Modulation of CCR5 expression and R5 HIV-1 infection in primary macrophages exposed to sera from HESN, LTNP, and chronically HIV-1 infected people with or without natural antibodies to CCR5.

Modulation of CCR5 expression and R5 HIV-1 infection in primary macrophages exposed to sera from HESN, LTNP, and chronically HIV-1 infected people with or without natural antibodies to CCR5.

Journal: Virus research
Published: October 17, 2024

The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.

The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.

Journal: Frontiers in immunology
Published: February 02, 2024

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.

Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.

Journal: Vaccines
Published: November 04, 2022

Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.

Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.

Journal: Frontiers in immunology
Published: December 23, 2021

Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection.

Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection.

Journal: Frontiers in immunology
Published: September 07, 2021

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.

HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.

Journal: Frontiers in immunology
Published: September 06, 2021

Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients.

Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients.

Journal: AIDS (London, England)
Published: May 16, 2021

Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases.

Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases.

Journal: Frontiers in immunology
Published: July 07, 2020

Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art.

Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art.

Journal: Frontiers in immunology
Published: April 14, 2020

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5.

The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5.

Journal: Viruses
Published: December 05, 2017

Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.

Induction of Antihuman C-C Chemokine Receptor Type 5 Antibodies by a Bovine Herpesvirus Type-4 Based Vector.

Journal: Frontiers in immunology
Published: August 10, 2017

The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.

The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.

Journal: Frontiers in immunology
Published: June 07, 2017
Showing 1-12 of 20

Last Updated: 09/26/2026